• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Obstetrics

Quick Take: Small for gestational age and risk of childhood mortality: A Swedish population study

byDonna LeetandAliya Ramjaun
December 27, 2018
in Obstetrics, Pediatrics, Public Health
Reading Time: 2 mins read
Stochastic resonance stimulation may decrease apnea of prematurity
Share on FacebookShare on Twitter

Small for gestational age (SGA) fetuses have been shown to have a higher risk of stillbirth and neonatal mortality, but few studies have examined long-term mortality. In this prospective cohort study, 3,795,603 non-malformed singleton live births and 2,781,464 full siblings born between January 1, 1973 and December 31, 2012 were examined to study the association between SGA and all-cause mortality between 28 days and less than 18 years of age. SGA was defined as having a birth weight for gestational age less than the 10th percentile. SGA children were first compared with non-SGA children from the population, then to non-SGA siblings. Of the singleton births, 2.1% were born with severe SGA (<3rd percentile), and 5.7% with moderate SGA (3rd to <10th percentile). Researchers found that age-specific all-cause mortality rates were higher in children with severe SGA than in those with non-SGA in both the population (HR 2.58, 95% CI 2.38 to 2.80) and sibling (HR 2.61, 95% CI 2.19 to 3.10) analyses. The associations were strongest within the period of 28 days to <1 year of age (population-based: HR 4.46, 95% CI 3.98 to 5.00; sibling-based: HR 3.41, 95% CI 2.67 to 4.36). Age-specific all-cause mortality rates were also higher in children with moderate SGA (population-based: HR 1.37, 95% CI 1.28 to 1.47; sibling-based: HR 1.38, 95% CI 1.22 to 1.56). The strongest association of severe SGA with cause-specific mortality was death due to infection (population-based: HR 3.19; sibling-based: HR 4.24). In summary, this study indicates that being SGA is associated with an increased risk of childhood death through 18 years of age, and that infection is the most common cause of death.

Click to read the study in PLOS Medicine

Image: PD

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Anti-psychotic medication use during pregnancy not associated with attention-deficit/hyperactivity disorder, autism spectrum disorder or small for gestational age in children

#VisualAbstract: Longer-Term Assessment of Azithromycin for Reducing Childhood Mortality in Africa

The MORDOR II trial: mass azithromycin distribution decreases childhood mortality in Niger

Tags: childhood mortalitysmall for gestational age (SGA)
Previous Post

Quick Take: Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial

Next Post

New molecular probes for melanoma imaging and treatment [PreClinical]

RelatedReports

Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Obstetrics

Anti-psychotic medication use during pregnancy not associated with attention-deficit/hyperactivity disorder, autism spectrum disorder or small for gestational age in children

August 23, 2021
#VisualAbstract: Longer-Term Assessment of Azithromycin for Reducing Childhood Mortality in Africa
StudyGraphics

#VisualAbstract: Longer-Term Assessment of Azithromycin for Reducing Childhood Mortality in Africa

August 22, 2020
The MORDOR II trial: mass azithromycin distribution decreases childhood mortality in Niger
Pediatrics

The MORDOR II trial: mass azithromycin distribution decreases childhood mortality in Niger

June 8, 2019
Prognostic indicators for transarterial chemoembolization in patients with hepatocellular carcinoma with extrahepatic spread identified
Weekly Rewinds

2 Minute Medicine Rewind December 24, 2018

December 26, 2018
Next Post
Women with pregnancy-associated melanoma at greater risk of metastasis, recurrence

New molecular probes for melanoma imaging and treatment [PreClinical]

LUNG-RADS criteria increases positive predictive value for lung cancer detection in high-risk patients [Classics Series]

Quick Take: Long-term Outcomes of Tetralogy of Fallot: A Study From the Pediatric Cardiac Care Consortium

Quick Take: Long-term Outcomes of Tetralogy of Fallot: A Study From the Pediatric Cardiac Care Consortium

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • 2 Minute Medicine Rewind September 28, 2026
  • Nirsevimab (Beyfortus) may reduce severe respiratory syncytial virus infections among infants
  • An artificial intelligence (AI) tool achieved high diagnostic accuracy for the identification and prediction of sepsis
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.